Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
J R Rigas, M G Kris, V A Miller, et al.
The Annals of Thoracic Surgery
|
April 20, 2001
Preoperative chemotherapy for lung cancer does not increase surgical morbidity
M P Siegenthaler, K M Pisters, K W Merriman, et al.
The Annals of Thoracic Surgery
|
June 1, 1993
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients
N Martini, M G Kris, B J Flehinger, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 1, 2000
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team
K M Pisters, R J Ginsberg, D J Giroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
B S Glisson, J M Kurie, R Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer
K M Pisters, L B Tyson, W Tong, et al.
Annals of Internal Medicine
|
July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymoma
D M Shin, G L Walsh, R Komaki, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 30, 2021
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
A S Fung, D M Graham, E X Chen, et al.
Nature Medicine
|
September 1, 1996
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
J A Roth, D Nguyen, D D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
J Nemunaitis, S G Swisher, T Timmons, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
J R Rigas, M G Kris, V A Miller, et al.
The Annals of Thoracic Surgery
|
April 20, 2001
Preoperative chemotherapy for lung cancer does not increase surgical morbidity
M P Siegenthaler, K M Pisters, K W Merriman, et al.
The Annals of Thoracic Surgery
|
June 1, 1993
Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients
N Martini, M G Kris, B J Flehinger, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 1, 2000
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team
K M Pisters, R J Ginsberg, D J Giroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
B S Glisson, J M Kurie, R Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer
K M Pisters, L B Tyson, W Tong, et al.
Annals of Internal Medicine
|
July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymoma
D M Shin, G L Walsh, R Komaki, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 30, 2021
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
A S Fung, D M Graham, E X Chen, et al.
Nature Medicine
|
September 1, 1996
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
J A Roth, D Nguyen, D D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
J Nemunaitis, S G Swisher, T Timmons, et al.
Page
of 5